(Total Views: 412)
Posted On: 10/09/2025 4:07:29 PM
Post# of 158093
Novo Nordisk is buying Akero Therapeutics for up to $5.2 BN to gain access to a promising liver disease drug candidate.
The new CEO (since July) apparently likes effective Obesity and Diabetes drugs that can also treat related Cardiometabolic conditions...such as MASH.
The new CEO (since July) apparently likes effective Obesity and Diabetes drugs that can also treat related Cardiometabolic conditions...such as MASH.
(2)
(0)
